-
The Real-World Cost-Effectiveness of Faricimab Versus Existing and Future Biosimilars in Patients with Neovascular Age-Related Macular Degeneration in the UK
Mar 10, 2025, 14:00 PM -
AI-Enhanced Literature Review: Comparing Advanced Pancreatic Cancer Trial Outcomes According to Performance Status
Mar 10, 2025, 14:00 PM -
Parametric Model Selection: Beyond AIC/BIC in Health Economic Context
Mar 10, 2025, 14:00 PM -
Real World Treatment Patterns for Castration-Sensitive Prostate Cancer Between 2012 and 2024: A Systematic Review
Mar 10, 2025, 14:00 PM -
Review of NICE, PBAC, and CDA HTA Outcomes For Oncology Drugs Approved by the FDA Through Project Orbis (2022-2023)
Mar 10, 2025, 14:00 PM -
A Targeted Review of the Application of Discrete Event Simulation Modeling in CDA-AMC Assessments
Mar 10, 2025, 14:00 PM -
Novel Therapies for Neurofibromatosis Type 1-Associated Inoperable Plexiform Neurofibromas: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Development of a Patient Reported Outcome Measure for GastroIntestinal Recoveryafter Surgery (PRO-diGI)
Mar 10, 2025, 14:00 PM -
Comparison of Central Venous Access Device Insertion Proportions, Costs and Removal Time Between Subcutaneous and Intravenous Formulations of Pertuzumab and Trastuzumab in HER2+ Early Breast Cancer Patients
Mar 10, 2025, 14:00 PM -
Characteristics Correlated with Limited Physical Functioning in US Adults with Arthritis: A Cross-Sectional Database Analysis of the Medical Expenditure Panel Survey.
Mar 10, 2025, 14:00 PM -
Characteristics of Patients With Minimal Residual Disease (MRD) Testing for Solid Tumors in a United States Population With Commercial or Medicare Advantage (MA) Insurance
Mar 10, 2025, 14:00 PM -
Leveraging a Novel Mixed-Methods Approach to Deepen Insights From Exit Interviews and Trial Data in a Randomized Trial of Cancer Cachexia
Mar 10, 2025, 14:00 PM -
Indirect Treatment Comparison (ITC) of Mirdametinib and Selumetinib for the Treatment of Children with Neurofibromatosis Type 1-Associated Plexiform Neurofibromas (NF1-PN)
Mar 10, 2025, 14:00 PM -
Health Insurance Use Among Young Pharmacists in Nigeria
Mar 10, 2025, 14:00 PM -
Comparison of Selective Serotonin Reuptake Inhibitors and USA Food and Drug Administration-Approved Serotonin-Norepinephrine Reuptake Inhibitors Treatments for Fibromyalgia: A Systematic Review and Network Meta-Analysis
Mar 10, 2025, 14:00 PM -
Heredofamilial Amyloidosis Due to Transthyretin (hATTR): Cost Analysis From the Perspective of the Public Health Sector in Mexico
Mar 10, 2025, 14:00 PM -
Impact of Automated Insulin Delivery System (AID) Adoption on Concomitant Non-Insulin Diabetes Medications in Patients With Type 2 Diabetes for a U.S. Payer
Mar 10, 2025, 14:00 PM -
Trends of Mortality by Ulcer Decubitus in Colombia, 1998 - 2022
Mar 10, 2025, 14:00 PM -
US Commercial Health Plan Coverage of Oncology Therapies: 2017 - 2024
Mar 10, 2025, 14:00 PM -
Discordance Between Two Claims-Based Frailty Indices in a Hospitalized Medicare Population
Mar 10, 2025, 14:00 PM
